Shelter Pharma Limited (BOM:543963)

Shelter Pharma Statistics

Total Valuation

Shelter Pharma has a market cap or net worth of INR 597.78 million. The enterprise value is 557.18 million.

Market Cap	597.78M
Enterprise Value	557.18M

Important Dates

The next estimated earnings date is Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	Sep 23, 2025

Share Statistics

Shelter Pharma has 16.33 million shares outstanding. The number of shares has increased by 38.19% in one year.

Current Share Class	16.33M
Shares Outstanding	16.33M
Shares Change (YoY)	+38.19%
Shares Change (QoQ)	+76.13%
Owned by Insiders (%)	41.22%
Owned by Institutions (%)	n/a
Float	9.33M

Valuation Ratios

The trailing PE ratio is 7.12.

PE Ratio	7.12
Forward PE	n/a
PS Ratio	1.00
PB Ratio	0.99
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	39.16
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.87, with an EV/FCF ratio of -43.54.

EV / Earnings	6.79
EV / Sales	0.93
EV / EBITDA	4.87
EV / EBIT	5.03
EV / FCF	-43.54

Financial Position

The company has a current ratio of 7.95, with a Debt / Equity ratio of 0.02.

Current Ratio	7.95
Quick Ratio	3.05
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	-0.95
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.40% and return on invested capital (ROIC) is 13.53%.

Return on Equity (ROE)	16.40%
Return on Assets (ROA)	12.60%
Return on Invested Capital (ROIC)	13.53%
Return on Capital Employed (ROCE)	17.99%
Revenue Per Employee	8.68M
Profits Per Employee	1.19M
Employee Count	69
Asset Turnover	1.09
Inventory Turnover	3.32

Taxes

In the past 12 months, Shelter Pharma has paid 27.59 million in taxes.

Income Tax	27.59M
Effective Tax Rate	25.17%

Stock Price Statistics

The stock price has decreased by -31.42% in the last 52 weeks. The beta is 0.41, so Shelter Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-31.42%
50-Day Moving Average	42.36
200-Day Moving Average	43.25
Relative Strength Index (RSI)	39.06
Average Volume (20 Days)	27,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shelter Pharma had revenue of INR 598.96 million and earned 82.02 million in profits. Earnings per share was 5.14.

Revenue	598.96M
Gross Profit	156.89M
Operating Income	110.77M
Pretax Income	109.61M
Net Income	82.02M
EBITDA	114.34M
EBIT	110.77M
Earnings Per Share (EPS)	5.14

Balance Sheet

The company has 52.80 million in cash and 12.20 million in debt, giving a net cash position of 40.60 million or 2.49 per share.

Cash & Cash Equivalents	52.80M
Total Debt	12.20M
Net Cash	40.60M
Net Cash Per Share	2.49
Equity (Book Value)	606.83M
Book Value Per Share	52.45
Working Capital	369.66M

Cash Flow

In the last 12 months, operating cash flow was 15.27 million and capital expenditures -28.06 million, giving a free cash flow of -12.80 million.

Operating Cash Flow	15.27M
Capital Expenditures	-28.06M
Free Cash Flow	-12.80M
FCF Per Share	-0.78

Margins

Gross margin is 26.19%, with operating and profit margins of 18.49% and 13.69%.

Gross Margin	26.19%
Operating Margin	18.49%
Pretax Margin	18.30%
Profit Margin	13.69%
EBITDA Margin	19.09%
EBIT Margin	18.49%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.92%.

Dividend Per Share	0.35
Dividend Yield	0.92%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	4.65%
Buyback Yield	-38.19%
Shareholder Yield	-37.27%
Earnings Yield	13.72%
FCF Yield	-2.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5